Bhinneka News Online: Reuters Health Report: April 21, 2017

Friday, 21 April 2017

Reuters Health Report: April 21, 2017

Click to View in Browser

Friday, April 21, 2017

Regular exercise may improve odds of surviving a heart attack

(Reuters Health) - Just a few hours a week of moderate exercise may not prevent all heart attacks, but it could make the difference in who survives one, Danish researchers say.

Teva's new asthma inhaler poses first competition for GSK's Advair

(Reuters) - Teva Pharmaceutical Industries Ltd on Thursday launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline's best-selling Advair.

Regulator links Sanofi epilepsy drug to child deformities

PARIS (Reuters) - Up to 4,100 children in France suffered major malformations in the womb after their mothers took a treatment against epilepsy and bipolar disorders known as valproate between 1967 and 2016, France's drug regulator said.

Biotech firm pulls pioneering gene therapy due to no demand

LONDON (Reuters) - The biotech company behind the Western world's first gene therapy and the most expensive prescription medicine in history is giving up on the product because of lack of demand.

GSK must pay $3 million in generic Paxil suicide lawsuit: U.S. jury

(Reuters) - GlaxoSmithKline must pay $3 million to a woman who sued the drug company over the death of her husband, a lawyer who committed suicide after taking a generic version of the antidepressant Paxil, a U.S. jury said on Thursday.

Uninsured with traumatic injuries may be cured into destitution

(Reuters Health) - When a badly injured patient rolls into the emergency room, Dr. John Scott doesn't ask to see proof of insurance. Instead, he immediately begins treatment.

Diabetes control tied to heart stent outcomes

(Reuters Health) - For people with type 2 diabetes, maintaining good blood sugar control in the years after receiving a coronary artery stent is associated with a lower risk of heart attack and stroke, according to a recent study.

Two-horse race: Auris, Otonomy seek FDA nod for inner-ear therapies

(Reuters) - Doctors have struggled for years to deliver medication effectively to the inner ear, but two companies are vying to be first to introduce new treatments which, if successful, could together chalk up some $800 million in peak sales.

GREEN Tool offers evidence-based guidance for school garden success

(Reuters Health) – Planting a successful school garden requires a lot more than just soil, seeds and water, say researchers who have come up with a planning tool that can help ensure school gardens thrive and endure.

Rape victims in U.S. made to pay part of the medical bill

(Reuters Health) - Women who have been sexually assaulted in the U.S. often bear some costs for testing and other medical treatment when they report the rape to authorities, according to a new study.